Efficacy of entecavir versus tenofovir disoproxil fumarate in treatment of chronic hepatitis B patients with high viral load. (Theme Issue: New advances in the precise diagnosis and treatment of liver cancer.) [Chinese]
Journal of Clinical Hepatology
; 38(3):532-536, 2022.
Article
in Chinese
| GIM | ID: covidwho-1780130
ABSTRACT
Objective:
To investigate the efficacy of entecavir (ETV) versus tenofovir disoproxil fumarate (TDF) and the treatment measures for poor response in previously untreated chronic hepatitis B (CHB) patients with high viral load.
147127-20-6; 209216-23-9; 9000-86-6; human diseases; efficacy; drug therapy; viral load; patients; hepatitis B; antiviral agents; viral diseases; risk factors; chronic infections; liver; viral hepatitis; liver diseases; tenofovir; entecavir; alanine aminotransferase; analogues; cirrhosis; cross resistance; hepatocellular carcinoma; infectious diseases; multivariate analysis; neoplasms; regimens; responses; man; Hepatitis B virus; Severe acute respiratory syndrome coronavirus 2; Hepatovirus A; China; Guangxi; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Orthohepadnavirus; Hepadnaviridae; DNA Reverse Transcribing Viruses; viruses; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; Central Southern China; Hepatovirus; Picornaviridae; Picornavirales; chemotherapy; antivirals; viral infections; People's Republic of China; SARS-CoV-2; glutamate pyruvate transaminase; glutamic pyruvic transaminase; Gpt; analogs; liver cirrhosis; Kwangsi; communicable diseases; cancers
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS